Publication | Closed Access

Potential Role of Histone Deacetylase Inhibitors in Mesothelioma: Clinical Experience with Suberoylanilide Hydroxamic Acid

OncologySuberoylanilide Hydroxamic AcidMedicineHistone Deacetylase InhibitorsPathologyPotential RoleAnti-cancer AgentCancer TreatmentPharmacologyTumor MicroenvironmentCancer Research